Topics:

A new agent, AZD9291, showed promising clinical activity and progression-free survival in a study of patients with advanced stage, EGFR mutation-positive NSCLC.

Data from the LUX-Lung 8 trial showed afatinib outperformed erlotinib with regard to both progression-free and overall survival in squamous cell lung cancer.

Pembrolizumab demonstrated a 24.8% overall response rate in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

Health care is a big target for data breaches, according to experts at SIIM 2015.

Immediate ADT improved overall survival compared with delayed ADT in prostate cancer patients with a rising prostate-specific antigen level.

Elective neck lymph node surgery for patients with early oral cancer reduces the risk of cancer recurrence and improves survival.

©Ismagilov/Shutterstock.com

Rates of severe mental illness in children and adolescents have dropped 16% since 1996, according to a new study. The lead author explains possible reasons for this surprising finding and concludes: "We're moving in the right direction!"

A new study of amyloid PET brings imaging to the forefront of research for Alzheimer's disease.

Pages

Subscribe to Cancer Network RSS

By clicking Accept, you agree to become a member of the UBM Medica Community.